Literature DB >> 24772050

Advances in the treatment of ulcerative colitis.

Laurent Peyrin-Biroulet1.   

Abstract

Entities:  

Year:  2013        PMID： 24772050      PMCID： PMC3999998     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics.

Authors:  Nicolas Williet; Claire Pillot; Abderrahim Oussalah; Vincent Billioud; Jean-Baptiste Chevaux; Laurent Bresler; Marc-André Bigard; Jean-Louis Gueant; Laurent Peyrin-Biroulet
Journal:  Inflamm Bowel Dis       Date:  2011-12-04       Impact factor: 5.325

2.  Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.

Authors:  William J Sandborn; Paul Rutgeerts; Brian G Feagan; Walter Reinisch; Allan Olson; Jewel Johanns; Jiandong Lu; Kevin Horgan; Daniel Rachmilewitz; Stephen B Hanauer; Gary R Lichtenstein; Willem J S de Villiers; Daniel Present; Bruce E Sands; Jean Frédéric Colombel
Journal:  Gastroenterology       Date:  2009-07-28       Impact factor: 22.682

Review 3.  Review article: the role of anti-TNF in the management of ulcerative colitis -- past, present and future.

Authors:  S Danese; J-F Colombel; L Peyrin-Biroulet; P Rutgeerts; W Reinisch
Journal:  Aliment Pharmacol Ther       Date:  2013-03-13       Impact factor: 8.171

Review 4.  Histologic remission: the ultimate therapeutic goal in ulcerative colitis?

Authors:  Laurent Peyrin-Biroulet; Aude Bressenot; Wendy Kampman
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-01       Impact factor: 11.382

5.  Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials.

Authors:  Alexander C Ford; Laurent Peyrin-Biroulet
Journal:  Am J Gastroenterol       Date:  2013-05-07       Impact factor: 10.864
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.